What if a new combination of cancer drugs could sound an alarm, alerting the body's immune system to invoke a targeted response to cancer cells? Findings from a new study appear in a paper published in Nucleic Acids Research.
Jun 11, 2026
0
5
Scientists have made great progress in harnessing the body's own immune cells to treat so-called liquid tumors, cancers of the blood and lymphatic system. Yet these powerful cell therapies have been no match for solid tumors, ...
Jun 11, 2026
0
6
Daniel Daneshvar, MD, Ph.D., director of the HealthSpan Lab and Chief of the Department of Physical Medicine and Rehabilitation at Mass General Brigham, and Charlotte Luster, of the HealthSpan Lab, are the senior and lead ...
Jun 10, 2026
0
4
If you regularly drink soda or other sugary beverages, a new study may give you a reason to cut back.
Jun 10, 2026
0
4
An unexpected lab observation has led a team of scientists to discover how diet can influence survival in animal models of glioma, one of the most aggressive and deadly forms of brain cancer. Researchers at Baylor College ...
Jun 10, 2026
0
6
One of the most detailed maps to date of meningioma—the most common brain tumor in adults—reveals how the tumor's surrounding environment helps drive disease behavior and patient outcomes, according to new research from Mayo ...
Jun 10, 2026
0
6
Many of the deadliest forms of cancer are caused by a pathological mutation in the RAS protein. Yet, to date, no effective treatment for this cancer protein has been found. A new research approach aims to prevent the protein ...
Jun 10, 2026
0
16
A new study by investigators from Mass General Brigham Cancer Institute has found that an ultrasensitive blood test called HPV-DeepSeek could help identify which people with HPV-associated head and neck cancer still had cancer ...
Jun 10, 2026
0
3
A Northwestern Medicine study has offered new clues as to why immunotherapy works well for some bladder cancer patients but fails for others, according to a study published in the Journal of Clinical Investigation.
Jun 10, 2026
0
2
In 2020, Jennifer Doudna won the Nobel Prize in chemistry for her work on the CRISPR-Cas9 gene-editing technology that allows scientists to precisely modify DNA by cutting it at specific locations. Six years later, a new ...
